Teresa Gonzalo

After receiving her MBA from IE Business School and a PhD in nanomedicine from Groningen University in Holland, Teresa became the head of the U.S. office for Venture Valuation, where her global team evaluated healthcare companies facing a fundraising event, licensing deals, or an M+A transaction. She was also the CEO and co-founder of Ambiox Biotech (application of dendrimer nanotechnology for antiviral treatment). Teresa regularly speaks at healthcare conferences in the Pharma/Biotech and Medtech sectors. She has co-authored two patents in nanotechnology and drug delivery and was named the 2011 MIT TR35 Innovator of the Year by the Massachusetts Institute of Technology. Teresa was among the top 100 women leaders in Spain in the entrepreneurial and innovative category for two consecutive years in 2012 and 2013. In addition, she was selected as Woman of the Year by Scientific Entrepreneurial Woman Today magazine .
At VERTESS, Teresa is a Managing Director with considerable expertise in Pharma/Biotech, Medtech, Diagnostics, Healthcare IT, CRO, and related healthcare verticals. She is dedicated to providing enhanced value to M+A transactions.

Posts by Teresa Gonzalo